Literature DB >> 28592849

Imaging grading system for the diagnosis of dural ossification based on 102 segments of TOLF CT bone-window data.

Sheng-Yuan Zhou1, Bo Yuan1, Xiong-Sheng Chen2, Xue-Bin Li1, Wei Zhu1, Lian-Shun Jia1.   

Abstract

Thoracic ossification of the ligamentum flavum (TOLF) complicated with dural ossification (DO) is a severe clinical disease. The diagnosis of DO preoperatively remains challenging. The current study retrospectively analyzed imaging features of 102 segments with TOLF from 39 patients and proposed a grading system for evaluating DO risk. Logistic regression results showed that unilateral spinal canal occupational rate (UCOR), tram track signs, and C-signs were all risk factors for DO (odds ratios of 5.393, 19.734 and 72.594, respectively). In validation analyses for the TOLF-DO grading system, sensitivity was 76.0% (19/25), specificity was 91.0% (70/77), and Youden's index was 0.66. Thus, implementation of the TOLF-DO grading system has the potential to improve the diagnosis of DO.

Entities:  

Mesh:

Year:  2017        PMID: 28592849      PMCID: PMC5462817          DOI: 10.1038/s41598-017-03178-x

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


Introduction

Thoracic ossification of the ligamentum flavum (TOLF) complicated with dural ossification (DO) is an uncommon but severe clinical entity[1-4]. The pathogenesis of DO remains unclear at present. The diagnosis of DO usually depends on the finding of an “ossified mass” unseparated from the dural sac during operation. Surgical treatment for TOLF-DO is more difficult and risky than simple TOLF[5-9]. If the presence of DO can be confirmed preoperatively, the safety of the surgical procedure can be ensured to a greater extent. However, it is still difficult to confirm the diagnosis of DO preoperatively based on patient history, clinical observation, and imaging presentation. Imaging research regarding TOLF-DO is relatively rare. Muthukumar et al.[10] and Sun et al.[11] reported that the presence of a “tram track sign” (i.e., a hyperdense bony excrescence with a hypodense center) or “comma sign” (i.e., evidence of ossification of one-half of the circumference of the dura mater) on transverse computed tomography (CT) or magnetic resonance imaging (MRI) scans was significant for the diagnosis of DO. In retrospective case data, both tram track signs and comma signs could be seen in the imaging of TOLF-DO patients. In clinical practice, the ossified mass of the TOLF-DO segment is frequently hypertrophied, while the less hypertrophic adjacent segments are usually not complicated with DO. This pattern suggests that the degree of hypertrophy in the ossified mass may be associated with the occurrence of DO. In the present study, we retrospectively analyzed imaging features of the segments definitely affected by TOLF-DO and compared them to those of TOLF patients without DO. Based on the statistical results, we propose a grading system for evaluating DO risk and offer this system as a practical tool for the diagnosis of TOLF-DO.

Results

Demographic and clinical characteristics

The study sample included a total of 102 segments with TOLF from 39 patients. Twenty-five of these segments were diagnosed with TOLF-DO, and the other 77 segments were diagnosed as TOLF without DO (TOLF-NDO). The morphological features of the involved segments were observed on bone-window CT transverse images. DO segment locations are listed in Table 1.
Table 1

Segments locations of patients with TOLF.

TOLF-DOTOLF-NDO
C7/T1 01
T1/2 04
T2/3 16
T3/4 15
T4/5 05
T5/6 24
T6/7 22
T7/8 13
T8/9 23
T9/10 612
T10/11 520
T11/12 59
T12/L1 03
Segments locations of patients with TOLF. The percentage of patients with TOLF-DO in our series of patients was 41.0% (16/39), and the percentage of segments affected by TOLF-DO was 24.5% (25/102). T9–T12 were the segments most commonly affected by DO, accounting for 64% of DO cases (16/25).

TOLF-DO Grading system

We divided unilateral spinal canal occupational rate (UCOR) measurements for 102 TOLF segments into four ranges (0–50%, 50–59%, 60–69%, and 70–100%). The incidence of DO increased gradually with increases in UCOR values. For UCOR values ≥ 60%, the incidence rate of TOLF-DO was higher than that of TOLF-NDO. Tram track sign and C-sign rates in DO segments were also higher than in NDO segments (Fig. 1).
Figure 1

Distribution of UCOR, tram track sign and C-sign values. UCOR indicates unilateral spinal canal occupational rate. TTS indicates the tram track sign. CS indicates the C-sign. NDO indicates TOLF without DO. DO indicates TOLF with DO.

Distribution of UCOR, tram track sign and C-sign values. UCOR indicates unilateral spinal canal occupational rate. TTS indicates the tram track sign. CS indicates the C-sign. NDO indicates TOLF without DO. DO indicates TOLF with DO. Logistic regression results indicated that UCOR, tram track sign and C-sign were all risk factors for DO (Table 2). Based on odds ratios calculated from this model, we designed a TOLF-DO grading system (Table 3). The system comprised 4 total points, and the existence of DO was highly suspected when the score was greater than 2 points.
Table 2

Odds ratio of TTS, CS and UCOR ≥ 60%.

VariableOdds ratio with 95% CIP value
TTS19.734 (3.364, 115.758)0.001
CS72.594 (5.467, 963.961)0.001
UCOR ≥ 60%5.393 (1.021, 28.468)0.047
Table 3

TOLF-DO grading system.

ParameterScore
Unilateral COR value
<60%0
≥60%1
Radiological features
Tram track sign1
C-sign2
Tram track sign + C-sign3

The existence of DO was highly suspected when the score was larger than 2 points.

Odds ratio of TTS, CS and UCOR ≥ 60%. TOLF-DO grading system. The existence of DO was highly suspected when the score was larger than 2 points.

Clinical validation of the TOLF-DO grading system

Figure 2 displays the distribution of TOLF-DO risk scores across the 102 segments. Table 2 displays the results of the logistic regression analysis. Tram track sign, C-sign and UCOR ≥ 60% were all risk factors for DO. Table 4 lists diagnostic outcomes for the TOLF-DO grading system and intraoperative diagnosis.
Figure 2

Results of the TOLF-DO grading system and score distribution for the 102 segments.

Table 4

The comparison of diagnostic outcomes in TOLF-DO grading system and Intraoperative diagnosis.

TOLF-DO grading system
+
Intraoperative diagnosis+196
770

Sensitivity = 19/25 * 100% = 76.0%. Specificity = 70/77 * 100% = 91.0%. Positive predictive value = 19/26 * 100% = 73.1%. Negative predictive value = 70/76 * 100% = 92.1%. Youden’s index = 0.76 + 0.90 − 1 = 0.66. Crude agreement rate = (19 + 70)/(19 + 6 + 7 + 70) * 100% = 87.3%.

Results of the TOLF-DO grading system and score distribution for the 102 segments. The comparison of diagnostic outcomes in TOLF-DO grading system and Intraoperative diagnosis. Sensitivity = 19/25 * 100% = 76.0%. Specificity = 70/77 * 100% = 91.0%. Positive predictive value = 19/26 * 100% = 73.1%. Negative predictive value = 70/76 * 100% = 92.1%. Youden’s index = 0.76 + 0.90 − 1 = 0.66. Crude agreement rate = (19 + 70)/(19 + 6 + 7 + 70) * 100% = 87.3%.

Discussion

TOLF-DO is not uncommon in TOLF. Clinical data in the current study suggested that the incidence of TOLF-DO was 41.0%, compared to estimates of 14% to 61% in previous literature[2–4, 12, 13]. DO often occurs at lower thoracic segments, and the affected region was located at T9–12 for 16 of the 25 segments in our series. Other studies have also reported DO most frequently at T9–12. This region is also the preferred site for TOLF[14-16]. We retrospectively reviewed CT bone window imaging data for 102 TOLF segments. “Comma signs” had more diagnostic value than “tram track signs” for TOLF-DO. The tram track sign was observed in 17 segments, but the “C-sign” was observed in only one TOLF-NDO segment. The relationship between tram track signs and DO thus requires further clarification. Some researchers have found that a layered presentation (i.e., double-layer sign) in the ossified mass of the posterior longitudinal ligament (OPLL) or a C-shaped (C-sign) high-density ossified zone on the side of the dura is valuable for the diagnosis of DO[17-19]. The low-density zone in the double-layer sign has been explained as an immature ossified ligament[20, 21] in the ossified mass. The double-layer sign also indicates that OPLL originates from the dura-side ligament, which increases the possibility that it is accompanied by DO[16, 18, 22]. Although tram track sign is not a unique imaging feature of TOLF-DO, the existence of DO should be highly suspected in cases where the C-sign is observed. Accordingly, the proposed grading system highlights the diagnostic value of C-sign in DO. The incidence of DO is apparently correlated with the progress of TOLF[23]. DO was not observed when the UCOR value was lower than 40%; in contrast, the risk of DO increased significantly when UCOR was at least 60%. To date, no studies have reported a correlation between the occurrence of DO and the thickness of the ossified mass. More TOLF patients are needed to validate the diagnostic significance of TOLF-DO. There is no uniform method to measure COR values in TOLF. The simple and practical measurement of UCOR values for TOLF that we recommend in this study was based on the origin and progression of OLF. The TOLF-DO grading system had a high specificity (91%) for the diagnosis of DO. For scores less than 2 points, the existence of DO was not suspected. In contrast, the sensitivity was 76%, indicating a 24% rate of missed DO diagnoses. According to the distribution of UCOR values, 10 segments in the 12 cases with UCOR ≥ 70% were diagnosed with DO. We did not evaluate the grading system for UCOR values ≥ 70% because the number of cases meeting this criterion was relatively small. However, according to our clinical experience, the presence of DO should be highly suspected when UCOR values exceed 70%. The grading system setting and clinical validation were both based on a relatively small number of cases. The feasibility and significance of applying this system to the diagnosis of DO require further investigation with larger sample sizes and in multicenter clinical studies.

Methods

Ethics statement

The treatment protocol and informed consent were approved by the Shanghai Changzheng Hospital Institutional Review Board, and all subjects gave informed consent. All methods were performed in accordance with the Declaration of Helsinki.

CT Imaging examination

Tram track sign and C-sign

The TTS is a hyperdense bony excrescence with a hypodense center (Fig. 3a)[10]. The edges of the bilateral dura-side ossified mass are curved, forming a “C” sign (Fig. 3b). The C-sign includes all the manifestations of the comma sign[10].
Figure 3

(a) Schematic diagram (left) and CT transverse scan (right) of the tram track sign; (b) Schematic diagram (left) and CT transverse scan (right) of the C-sign.

(a) Schematic diagram (left) and CT transverse scan (right) of the tram track sign; (b) Schematic diagram (left) and CT transverse scan (right) of the C-sign.

Measurement of unilateral spinal canal occupational rate (UCOR) for the ossified mass

OR severity was measured on CT transverse images. The ossified mass of the OLF originates from the bilateral laminae and facet joints, and it then spreads to the midline and posterior vertebral wall. The maximum thickness of the unilateral ossified mass (d) and the distance from the lamina to the midpoint of the posterior vertebral wall (D) were measured. The ratio of d/D was calculated, and the larger value was set as the UCOR (Fig. 4).
Figure 4

UCOR measurements for the ossified mass, where UCOR = d/D × 100%. (a) Schematic diagram of the measuring method. (b) Measurement on CT transverse scan through facet joint. (c) Measurement on CT transverse scan through vertebral lamina.

UCOR measurements for the ossified mass, where UCOR = d/D × 100%. (a) Schematic diagram of the measuring method. (b) Measurement on CT transverse scan through facet joint. (c) Measurement on CT transverse scan through vertebral lamina.

Establishment and clinical validation of the TOLF-DO Grading system

Logistic regression was used to evaluate risk factors for TOLF-DO. According to odds ratios for multiple risk factors, we established a TOLF-DO grading system for evaluating risk for DO. The 102 TOLF segments were evaluated using the TOLF-DO grading system. Intraoperative diagnosis was used as the gold standard. The sensitivity and specificity of the grading system for diagnosis of TOLF-DO were calculated.

Statistical Analysis

Multivariate analyses of risk factors for TOLF-DO were carried out with logistic regression to determine odds ratios (OR) and their 95% confidence intervals (95% CI). A two-tailed P value less than 0.05 was regarded as statistically significant. All statistical analyses were performed using SPSS (version 18.0, SPSS Inc., Chicago, IL).
  22 in total

Review 1.  Diagnosis and surgical management of cervical ossification of the posterior longitudinal ligament.

Authors:  Nancy Epstein
Journal:  Spine J       Date:  2002 Nov-Dec       Impact factor: 4.166

2.  Diagnosis and treatment of ossification of the ligamentum flavum associated with dural ossification: clinical article.

Authors:  Xin-Zhi Sun; Zhong-Qiang Chen; Qiang Qi; Zhao-Qing Guo; Chui-Guo Sun; Wei-Shi Li; Yan Zeng
Journal:  J Neurosurg Spine       Date:  2011-07-01

3.  Predictive factors for a poor surgical outcome with thoracic ossification of the ligamentum flavum by multivariate analysis: a multicenter study.

Authors:  Kei Ando; Shiro Imagama; Zenya Ito; Kenichi Hirano; Akio Muramoto; Fumihiko Kato; Yasutsugu Yukawa; Noriaki Kawakami; Koji Sato; Yuji Matsubara; Tokumi Kanemura; Yukihiro Matsuyama; Naoki Ishiguro
Journal:  Spine (Phila Pa 1976)       Date:  2013-05-20       Impact factor: 3.468

4.  Surgical treatment of 40 patients with thoracic ossification of the ligamentum flavum.

Authors:  Fangcai Li; Qixin Chen; Kan Xu
Journal:  J Neurosurg Spine       Date:  2006-03

5.  Bone window computed tomography for detection of dural defect associated with cervical ossified posterior longitudinal ligament.

Authors:  K Hida; Y Iwasaki; I Koyanagi; H Abe
Journal:  Neurol Med Chir (Tokyo)       Date:  1997-02       Impact factor: 1.742

6.  Surgical Technique for Decompression of Severe Thoracic Myelopathy due to Tuberous Ossification of Ligamentum Flavum.

Authors:  Ting Wang; Chuqiang Yin; Dechun Wang; Shuzhong Li; Xiaoliang Chen
Journal:  Clin Spine Surg       Date:  2017-02       Impact factor: 1.876

7.  Thoracic myelopathy secondary to ossified ligamentum flavum.

Authors:  P Trivedi; S Behari; L Paul; D Banerji; V K Jain; D K Chhabra
Journal:  Acta Neurochir (Wien)       Date:  2001-08       Impact factor: 2.216

8.  Thoracic ossification of ligamentum flavum caused by skeletal fluorosis.

Authors:  Wenbao Wang; Linghua Kong; Heyuan Zhao; Ronghua Dong; Jianjiang Li; Zhanhua Jia; Ning Ji; Shucai Deng; Zhiming Sun; Jing Zhou
Journal:  Eur Spine J       Date:  2006-10-31       Impact factor: 3.134

9.  Factors related to long-term outcome after decompressive surgery for ossification of the ligamentum flavum of the thoracic spine.

Authors:  Naohisa Miyakoshi; Yoichi Shimada; Tetsuya Suzuki; Michio Hongo; Yuji Kasukawa; Kyoji Okada; Eiji Itoi
Journal:  J Neurosurg       Date:  2003-10       Impact factor: 5.115

10.  Surgical treatment of ossification of the ligamentum flavum associated with dural ossification in the thoracic spine.

Authors:  Zhong Yang; Yuan Xue; Chao Zhang; Qin Dai; Huifang Zhou
Journal:  J Clin Neurosci       Date:  2012-12-23       Impact factor: 1.961

View more
  2 in total

1.  Identification of the molecular mechanism and diagnostic biomarkers in the thoracic ossification of the ligamentum flavum using metabolomics and transcriptomics.

Authors:  Jiahao Li; Lingjia Yu; Shigong Guo; Yu Zhao
Journal:  BMC Mol Cell Biol       Date:  2020-05-13

2.  The diagnostic accuracy of CT-based "Banner cloud sign" for dural ossification in patients with thoracic ossification of the ligamentum flavum: a prospective, blinded, diagnostic accuracy study protocol.

Authors:  Guanghui Chen; Baoliang Zhang; Liyuan Tao; Zhongqiang Chen; Chuiguo Sun
Journal:  Ann Transl Med       Date:  2020-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.